These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38228284)
1. Personalized medicine in ocular oncology: a brighter future for eye cancer care. Dalvin LA Can J Ophthalmol; 2024 Aug; 59(4):e299-e300. PubMed ID: 38228284 [No Abstract] [Full Text] [Related]
2. A transformation in ocular oncology: from megacenter to multicenter. Harbour JW Arch Ophthalmol; 2010 Mar; 128(3):367-8. PubMed ID: 20212211 [No Abstract] [Full Text] [Related]
6. Ocular oncology and the study of rare cancers. Margo CE Cancer Control; 2004; 11(5):283-4. PubMed ID: 15377986 [No Abstract] [Full Text] [Related]
7. The Development of Ocular Oncology. Watching a Dream Come True. Shields JA; Shields CL Asia Pac J Ophthalmol (Phila); 2017; 6(2):107-108. PubMed ID: 28399344 [No Abstract] [Full Text] [Related]
8. [Ophthalmic oncology: achievements over the last two decades]. Brovkina AF; Panova IE; Saakian SV Vestn Oftalmol; 2014; 130(6):13-9. PubMed ID: 25715547 [TBL] [Abstract][Full Text] [Related]
11. Ocular oncology service during the COVID-19 outbreak in Florence (Italy): Practical considerations for the management of patients. Mazzini C; Pieretti G; Vicini G; Nicolosi C; Giattini D; Calamita R; Santoro N; Giansanti F Eur J Ophthalmol; 2021 Mar; 31(2):NP4-NP7. PubMed ID: 33238727 [TBL] [Abstract][Full Text] [Related]
12. Hematology/Oncology Clinics of North America. Melanoma. Preface. Hodi FS Hematol Oncol Clin North Am; 2014 Jun; 28(3):xiii-xiv. PubMed ID: 24880951 [No Abstract] [Full Text] [Related]
13. Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of Shi Y; Iorgulescu JB; Valladao S; Atibalentja DF JCO Precis Oncol; 2024 May; 8():e2400068. PubMed ID: 38815181 [TBL] [Abstract][Full Text] [Related]
14. Referral patterns of intraocular tumour patients to a dedicated Canadian ocular oncology department. Law C; Krema H; Simpson ER Can J Ophthalmol; 2012 Jun; 47(3):254-61. PubMed ID: 22687302 [TBL] [Abstract][Full Text] [Related]
15. Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus. Manjandavida FP; Honavar SG; Kim U; Singh U; Menon V; Das S; Kaliki S; Palanivelu MS; Khetan V; Shah PK; Rishi P; Mulay K; Gandhi A; Vadhiraja BM; Reddy VA; Bhat S; Rao V Indian J Ophthalmol; 2020 Jul; 68(7):1281-1291. PubMed ID: 32587152 [TBL] [Abstract][Full Text] [Related]
16. [Current diagnostics and therapy recommendations for ocular basal cell carcinoma]. Kakkassery V; Loeffler KU; Sand M; Koch KR; Lentzsch AM; Nick AC; Adamietz IA; Heindl LM Ophthalmologe; 2017 Mar; 114(3):224-236. PubMed ID: 27752782 [TBL] [Abstract][Full Text] [Related]
17. Personalized medicine in oncology: next generation. Chiang A; Million RP Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983 [No Abstract] [Full Text] [Related]
18. Oncologic imaging: a guiding hand of personalized cancer care. Hricak H Radiology; 2011 Jun; 259(3):633-40. PubMed ID: 21493796 [No Abstract] [Full Text] [Related]
19. The Future of Cancer Care: Are We Ready For Personalized Value? de Souza JA; Kelly C; Nabhan C J Natl Compr Canc Netw; 2015 Aug; 13(8):1049-51. PubMed ID: 26285249 [No Abstract] [Full Text] [Related]
20. Personalized medicine in oncology, the potential role of nuclear medicine imaging. Van de Wiele C; Mees G Curr Pharm Des; 2014; 20(14):2231-3. PubMed ID: 24025097 [No Abstract] [Full Text] [Related] [Next] [New Search]